Robert Andrade - 07 Jan 2026 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Andrade
Issuer symbol
FENC
Transactions as of
07 Jan 2026
Net transactions value
$0
Form type
4
Filing time
07 Jan 2026, 16:28:24 UTC
Previous filing
05 Jan 2026
Next filing
15 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Andrade Robert CHIEF FINANCIAL OFFICER C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK /s/ Robert Andrade 07 Jan 2026 0001468308

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $34,751 +14,184 +8% $2.45 191,100 07 Jan 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Options Exercise $34,751 -14,184 -1.7% $2.45 836,567 07 Jan 2026 Options 14,184 $2.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.